Literature DB >> 9640124

Gene therapy in autoimmune diseases.

C H Evans1, J D Whalen, C H Evans1, S C Ghivizzani, P D Robbins.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9640124      PMCID： PMC1752557          DOI： 10.1136/ard.57.3.125

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  19 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 2.  Gene therapy for arthritis: principles and clinical practice.

Authors:  R Kang; S C Ghivizzani; J H Herndon; P D Robbins; C H Evans
Journal:  Biochem Soc Trans       Date:  1997-05       Impact factor: 5.407

Review 3.  Biologic agents for treating rheumatoid arthritis. Concepts and progress.

Authors:  L W Moreland; L W Heck; W J Koopman
Journal:  Arthritis Rheum       Date:  1997-03

4.  Studies on the contribution of c-fos/AP-1 to arthritic joint destruction.

Authors:  S Shiozawa; K Shimizu; K Tanaka; K Hino
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

5.  Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery.

Authors:  E Raz; J Dudler; M Lotz; S M Baird; C C Berry; R A Eisenberg; D A Carson
Journal:  Lupus       Date:  1995-08       Impact factor: 2.911

6.  Transforming growth factor-beta gene therapy ameliorates experimental colitis in rats.

Authors:  E Giladi; E Raz; F Karmeli; E Okon; D Rachmilewitz
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-04       Impact factor: 2.566

7.  Systemic immunological effects of cytokine genes injected into skeletal muscle.

Authors:  E Raz; A Watanabe; S M Baird; R A Eisenberg; T B Parr; M Lotz; T J Kipps; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

8.  Treatment of murine lupus with CTLA4Ig.

Authors:  B K Finck; P S Linsley; D Wofsy
Journal:  Science       Date:  1994-08-26       Impact factor: 47.728

9.  Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

Authors:  M K Shaw; J B Lorens; A Dhawan; R DalCanto; H Y Tse; A B Tran; C Bonpane; S L Eswaran; S Brocke; N Sarvetnick; L Steinman; G P Nolan; C G Fathman
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307
View more
  4 in total

1.  Transduced viral IL-10 is exocytosed from lacrimal acinar secretory vesicles in a myosin-dependent manner in response to carbachol.

Authors:  Jiansong Xie; Ronald R Marchelletta; Padmaja B Thomas; Damon T Jacobs; Francie A Yarber; Richard E Cheney; Sarah F Hamm-Alvarez; Melvin D Trousdale
Journal:  Exp Eye Res       Date:  2008-11-13       Impact factor: 3.467

2.  Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc.

Authors:  B R Lawson; G J Prud'homme; Y Chang; H A Gardner; J Kuan; D H Kono; A N Theofilopoulos
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 3.  Gene therapy for autoimmune disorders.

Authors:  C H Evans; S C Ghivizzani; T J Oligino; P D Robbins
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

Review 4.  Newer drugs for the treatment of lupus nephritis.

Authors:  Dudy G Kuiper-Geertsma; Ronald H W M Derksen
Journal:  Drugs       Date:  2003       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.